All News

In this video from the 2026 American College of Cardiology Annual Scientific Session & Expo, Amy Sarma, MD, details associations of cardiovascular disease and menopause.

Azad and colleagues at Columbia University found that drug overdose, homicide, and suicide are the leading causes of death among pregnant and postpartum women.

Adnan I. Qureshi, MD, advocates for the integration of neurologists into obstetric teams to manage the increased stroke risk among pregnant persons with a previous stroke.

Take a quick look at our top 10 headlines from the first quarter of 2026.

Take a look back at some of the top FDA-related news items—from de Novo clearances to advancing trials—that Contemporary OB/GYN covered in the first quarter of 2026.

Simon highlights the "seamless handoff" between FQHCs and OB hospitalists as a vital mechanism for maintaining delivery access in rural and underserved communities.

A before-and-after cohort study of more than 18,000 patients found that universal aspirin 162 mg dispensation at the first prenatal visit was associated with a 29% reduction in preeclampsia with severe features, with benefit observed across patients with and without chronic hypertension and no increase in hemorrhagic complications.

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.

From FDA regulatory updates for products related to women's health, to a preview of upcoming annual meetings and conferences, we keep you updated on what's to come in Q2 of 2026.

The FDA informed manufacturers of its intent to issue draft guidance by August 2026 to regulate unapproved animal-derived thyroid medications used by 1.5 million Americans.

Researchers reported in JAMA Health Forum that while expanded prenatal syphilis mandates improve near-term detection, they require additional public health support to maintain long-term efficacy.

Clinicians evaluating women with new or worsening urinary incontinence should consider thyroid dysfunction—especially hypothyroidism—as a potential contributing factor, with overflow symptoms and systemic hypothyroid signs prompting laboratory evaluation and a comprehensive management approach.

Alla Vash-Margita, MD, FACOG, details how identifying differentially expressed microRNAs in 13- to 26-year-olds could provide a pathway for early detection of endometriosis.

Willow Innovations launched 7 new breastfeeding and maternal care accessories to support postpartum care from feeding to storage of breast milk.

Livi is a single-use, soft polyurethane foam device cleared by the FDA to absorb semen and vaginal discharge within approximately 60 seconds.

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.

ENDO-205 is EndoCyclic Therapeutics' lead program and consists of a first-in-class, non-hormonal targeted epeptide therapeutic for endometriosis, according to the company.

A 4857-patient international RCT found that a single postpartum infusion of IV ferric carboxymaltose was superior to twice-daily oral iron in achieving a non-anemic hemoglobin level at 6 weeks, with sustained hemoglobin benefit through 6 months across all regions studied.

Sangini Sheth, MD, emphasizes that shared decision-making is vital when presenting patients with the choice between clinician-collected and self-collected hrHPV screening options.

Flo Health chief medical officer Anna Klepchukova and study investigator Erica Stockwell highlight the benefits of digital symptom checkers for endometriosis.

Among a survey of over 800 providers, menopause care was the top area for expected greatest improvement over the next 5 years.

Sangini Sheth, MD, MPH, highlights that the updated HRSA guidelines empower patients by offering FDA-approved self-collection options for primary HPV testing.

Among 2029 women in Scandinavian countries who were followed up for 14 years, vaccine effectiveness was 100%.

A case report describes the first known use of low-intensity extracorporeal shock wave therapy for episiotomy scar pain, with a patient reporting meaningful improvement after more than 20 years of chronic pelvic floor dysfunction.

A retrospective study of more than 3200 cesarean deliveries found that patients with three or more prior cesareans have a 15% likelihood of a uterine window, supporting consideration of early-term delivery in this group.

Lam-Rachlin reported that the software did not add time to the examinations and, in some instances, appeared to speed up the process by providing a rapid preliminary analysis.

A randomized clinical trial found that weekly extended-release buprenorphine achieved significantly higher illicit opioid abstinence during pregnancy compared to daily sublingual doses.

A national EHR database study found that GLP-1 RA prescribing among perinatal patients increased more than thirtyfold between 2019 and 2024, with an estimated 20,000 pregnant individuals exposed in 2024 alone.